Hines is one of relatively few enrollees to have used the new Medicaid benefit, which weight loss doctors in the state say has been hindered by national drug shortages, the states prior authorization process for the drugs, and a lack of marketing
For instance, semaglutide has been approved and is being researched for indications including obesity, T2DM, reducing cardiovascular risk, chronic kidney disease, NAFLD, and AD, indicating that the development of new indications could provide new growth opportunities for GLP-1 drugs
Boland, M
Weight loss medications may make you lose your appetite and cravings for food, but they wont touch the underlying root causes of why you turned to food to soothe
(8) Mozaffarian, D., et al
Thondre, P